Hamps Bio Peer Comparison

BSE: 544312

₹25.00

₹0.00 (0.00%)

As on 23-Oct-2026IST

Market cap

₹22 Cr

Revenue (TTM)

₹8 Cr

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Edit

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Market cap (₹ Cr)	22	46,621	7,133	1,888	937
Revenue (₹ Cr)	8	6,725	7,229	137	287
Net Profit (₹ Cr)	-0.74	1,128.79	210.43	34.30	28.67
Net Margin (%)	-8.39	16.02	2.88	24.81	9.68
RoE (%)	-8.74	11.51	11.02	41.24	9.14
Price to Earnings	--	41.30	33.89	56.46	30.33
Price-To-Book	2.69	4.39	3.57	8.57	3.82

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Operating Revenue	8.47	6,430.65	6,892.47	137.42	277.86
Total Income	8.81	6,746.98	6,963.79	138.26	286.40
Total Expenditure	8.44	4,801.11	6,268.09	86.73	233.97
EBITDA	0.04	1,629.54	624.38	50.68	43.89
Depreciation	0.82	423.67	282.87	1.08	15.88
EBIT	-0.78	1,205.88	341.51	49.60	28.02
Interest	0.25	33.28	137.50	3.56	1.86
Other Income	0.33	316.33	71.32	0.84	8.55
Exceptional Items	--	-24.35	--	--	-5.78
Profit before Tax	-0.70	1,464.58	275.33	46.89	28.93
Provision for Tax	0.04	437.26	55.72	12.59	2.50
Profit after Tax	-0.74	1,027.32	219.61	34.30	26.43

Liabilities (₹ Cr)

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Shareholder's Funds	8.10	10,357.95	1,975.36	129.24	243.32
Minority Interest	--	--	-0.71	2.03	0.79
Non-Current Liabilities	4.15	482.17	1,225.00	25.98	14.83
Current Liabilities	3.62	1,608.40	763.90	27.58	30.79
Total Liabilities	15.92	12,448.52	4,084.80	184.83	300.10

Assets (₹ Cr)

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Non-Current Assets	10.57	4,921.74	1,820.29	86.31	101.01
Current Assets	5.30	7,526.79	2,143.26	98.52	188.72
Total Assets	15.92	12,448.52	4,084.80	184.83	300.10
Total Debt*	6.88	243.36	0.00	33.60	0.00
Net Current Assets	1.68	5,918.38	1,379.36	70.94	157.93
Contingent Liabilities	--	10.12	14.06	5.26	--

Cashflow (₹ Cr)

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Cash From Operating Activities	-0.71	1,031.39	495.58	10.64	-5.00
Cash Flow from Investing Activities	-2.93	137.73	-127.72	-62.70	-79.58
Cash from Financing Activities	3.72	-416.97	-255.51	61.28	-17.75
Net Cash Inflow / Outflow	0.07	752.14	112.36	9.22	-102.33

Ratios

Profitability Ratios

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
ROCE (%)	-3.35	14.96	22.22	44.38	13.29
ROE (%)	-8.74	10.56	11.93	41.24	11.95
ROA (%)	-5.17	8.70	6.00	26.21	9.31
EBIT Margin (%)	4.36	30.26	10.09	37.50	18.87
Net Margin (%)	-8.39	15.23	3.15	24.81	9.23
Cash Profit Margin (%)	0.92	22.56	7.19	25.74	15.23

Growth Ratios

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Revenue Growth (%)	27.08	14.50	12.33	78.48	16.21
EBIT Growth (%)	-59.89	31.25	26.01	99.55	14.03
Net Profit Growth (%)	-348.14	47.07	46.18	107.80	4.16
EPS Growth (%)	-348.14	47.07	45.68	54.78	-8.79
Book Value Growth (%)	-7.95	12.70	14.76	248.40	14.31

Valuation Ratios

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Price / Earnings	0.00	27.22	45.79	35.45	29.86
Price / Book Value	1.78	2.71	5.11	9.17	3.67
Dividend Yield (%)	0.00	1.18	0.00	0.00	0.00
EV/EBITDA	57.24	12.77	13.79	23.59	16.32
Market Cap (₹ Cr)	14.42	27,964.97	10,057.49	1,191.46	865.33

Solvency Ratios

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Debt to Equity	0.85	0.02	0.00	0.26	0.00
Short term debt to equity ratio	0.09	--	--	0.05	--
Current Ratio	1.46	4.68	2.81	3.57	6.13
Quick Ratio	0.75	3.60	1.00	2.82	5.42
Interest Coverage	-1.77	45.01	3.00	14.19	16.57

Operating Efficiency Ratios

	Hamps Bio	Gland Pharma	Medplus Health	Anondita Medicare	Laxmi Dental
Debtors to sales (%)	18.71	29.41	0.39	37.74	16.39
Asset Turnover	0.59	0.54	1.91	1.05	0.98
Receivable days	59.81	96.72	1.05	104.40	54.00
Inventory Days	106.86	97.32	71.25	45.49	26.54
Payable days	57.11	134.60	21.75	35.99	94.91
Cash Conversion Cycle	109.56	59.43	50.55	113.90	-14.37